Amarin Corp Plc (AMRN)

[caddiedad]

My thoughts regarding the Megyn Kelly Alzheimer’s podcast yesterday and edits to an earlier post why, IMO, the BRAVE study should show some relevance re: AMRN and Vascepa/Vazkepa.
150 different variables are associated with Alzheimer’s. Better said, it is viewed as “Network Insufficiency” within our brain. Since Vascepa has been shown to help mitigate cardiovascular disease and inflammatory symptoms, etc, the anticipated results from BRAVE should show us that it’s all about preventive measures we individually make, daily.

Plaque reduction is yet another benefit to check off the list that has already been studied using Vascepa.
Vascepa will be seen as a very beneficial supplement to assist in our daily lives and routines going forward and upcoming MITIGATE and BRAVE results should prove this.

The marketing regarding the purity of brand Vascepa will be our “yellow brick road” for our special molecule.
I’m now convinced that there will never be a cure for Alzheimer’s because it has to be prevented first, and the 150 variable factors (insulin resistance, sleep apnea, high cholesterol, stress, to name a few) will never be overcome all at once in the human body worldwide. No place on earth is immune from the killer disease.
Unfortunately 60% of those afflicted are women and that’s viewed as a hormonal factors.

Bring on BRAVE and the bigger BP that will inevitably connect the dots with this one drug to their pipeline.